鶹ý

Weekly Risperidone Win; Meta Hides Harmful Teen Content; Breathing to Altered State?

— News and commentary from the psychiatry world

MedpageToday
Illustration of a brain shaped maze.

A (LYN-005) was comparable to daily dosing with immediate-release risperidone (Risperdal) for schizophrenia and schizoaffective disorder in the phase III STARLYNG-1 trial, said developer Lyndra Therapeutics, which stopped the trial early due to the positive results.

Compared with high-dose with 52 mg, low-dose versions (13.5 mg or 19.5 mg) were linked with a reduced risk of new-onset depression. (The Lancet Regional Health Europe)

The number of new prescriptions dispensed nationally for Schedule II for attention deficit-hyperactivity disorder had a significant bump during the pandemic -- exceeding prepandemic rates. (JAMA Psychiatry)

suicide, self-harm, and eating disorder content to teen users. (The Hill)

Cutting back on stimulant use is a valid outcome and significantly improves health and recovery in , according to pooled data from 13 clinical trials. (Addiction)

Why are some psychiatrists ? (STAT)

Women with perinatal depression were at an , especially in the first year after diagnosis. (JAMA Network Open)

The "standard classification procedures are not (yet) followed" for , which was added to the DSM-5 in 2022, said authors of a paper in Harvard Review of Psychiatry.

for adolescents is both scarce and expensive, an NIH-supported analysis published in Health Affairs found.

Can patients breathe their way akin to psychedelic therapy? (New York Times)

Just 92 seconds of helped boost patients' ability to be hypnotized, allowing them to be treated with hypnosis-based therapy for fibromyalgia syndrome. (Nature Mental Health)

Individual was associated with symptoms of post-traumatic stress disorder among Black adolescents, and these symptoms were associated with suicidal ideation. (JAMA Psychiatry)

U.S. counties with reduced broadband internet access were almost three times more likely to and no outpatient facilities. (Nature Mental Health)

  • author['full_name']

    Kristen Monaco is a senior staff writer, focusing on endocrinology, psychiatry, and nephrology news. Based out of the New York City office, she’s worked at the company since 2015.